Laurus Labs Ltd

NSE: LAURUSLABS · BSE: 540222 · Pharmaceuticals & Biotechnology · 38 announcements

Share price: ₹2,050.00
Market cap: ₹1,10,764 Cr
Revenue (annual): ₹6,813 Cr
Net profit (annual): ₹888.8 Cr
P/E (TTM): 101.3×Sector 47.4×
Promoter holding: 27.47%-0.02% QoQ
FII holding: 28.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 6 Merger & Restructuring 5 Other Announcement 4 Financial Results 4 Board Meeting Outcome 4 Management Change 3 Results Update 2 Employee Stock Options 2 Dividend 2 Annual General Meeting 2 Results Correction 1 Credit Rating 1 Board Meeting Date 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

24 Jul 2026 14:57 IST BSE

Results Update

Laurus Labs Results Update

Laurus Labs reported Q1 FY27 revenue of ₹2,026 Crore and EBITDA of ₹644 Crore. The results show 29% year-on-year revenue growth.

Read the filing ↗

30 Apr 2026 15:26 IST NSE

Results Update

Laurus Labs Results Update

Laurus Labs announced its FY26 results, reporting ₹6,813 Crore in revenue with a 23% year-on-year growth. EBITDA reached ₹1,826 Crore with 26.8% margins, driven by strong CDMO performance and a better product mix. The company declared a second interim dividend of ₹1.2 per share and continues major CAPEX investments for future growth.

Value: ₹6,813 Cr

Read the filing ↗